经皮穿脾门静脉插管技术及其在肝癌介入治疗中的应用  

Technique of Percutaneous Transsplenic Portal Catheterization and Its Clinical Application in Interventional Treatment of Liver Cancer

作　　者：王建华[1] 邵国良[1] 颜志平[1] 程洁敏[1] 王小林[1] 龚高全[1] 刘清欣[1] 

机构地区：[1]复旦大学医学院附属中山医院放射科,上海200032

出　　处：《临床放射学杂志》2001年第5期385-387,共3页Journal of Clinical Radiology

基　　金：国家"九五"攻关课题基金资助项目!(96 - 90 7- 0 3- 0 1 )

摘　　要：目的　探讨经皮穿脾门静脉插管的可行性、操作技术及其在肝癌介入治疗中的应用价值。材料与方法　选用微创穿刺器械 ,对 2 3例需行门静脉插管介入治疗而不适合采用经皮穿肝或手术置管等方法的肝癌患者 ,在X线导引下采用经皮穿脾的方法行门静脉插管。结果　 2 0例 ( 86.96% )患者经皮穿脾门静脉插管获得成功 ,3例 ( 13 .0 4% )失败 (均因脾静脉穿刺失败 )。 1例( 4 .3 5 % )患者术后出现急性腹痛伴腹腔内出血 ,其余患者无严重并发症。结论　采用经皮穿脾途径行门静脉插管是一种可供选择的门静脉插管方法。Objective To investigate the feasibility and manipulating technique of percutaneous transsplenic portal catheterization (PTSPC), and to evaluate its application in interventional treatment of liver cancer.Materials and Methods Twenty three patients with liver cancer, who were not suitable for percutaneous transhepatic catheterization treatment, underwent PTSPC with microtraumatic puncture instruments under the guidance of fluoroscopy.Results PTSPC was successfully performed in 20 patients, and failed in 3 due to the failure of splenic vein puncture. After the procedure, one patient complained acute abdominal pain with intraabdominal hemorrhage and the blood pressure dropped. The patient recovered two weeks later through conservative treatment. No other significant complications occurred in the other patients.Conclusion PTSPC is safe and workable method for portal catheterization.

关 键 词：肝癌 脾静脉穿刺术 门静脉插管 介入疗法 

分 类 号：R735.7[医药卫生—肿瘤] R730.55[医药卫生—临床医学]